Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hansel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Pharmaceutical Sciences|September 26, 2009
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic propertiesZheng Yang, Lisa M Zadjura, Anthony M Marino, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretaseCarl P Bergstrom, Charles P Sloan, Wai-Yu Lau, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 2, 2009
Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme inductionM Zheng, J Wang, J Lubinski, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Hydroxytriamides as potent gamma-secretase inhibitorsC V C Prasad, Owen B Wallace, Jeffrey W Noonan, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretaseCarl P Bergstrom, Charles P Sloan, Henry H Wang, et al.
BMC Microbiology|July 10, 2026
Plasmids of co-circulating Staphylococcus aureus serve as vehicles for antimicrobial resistance sharing across diseased host-species at short timescalesKathryn R Piper, Ana Beatriz Garcez Buiatte, Stephanie S R Souza, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2004
Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitorD M Barten, V L Guss, J A Corsa, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Pharmaceutical Sciences|September 26, 2009
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic propertiesZheng Yang, Lisa M Zadjura, Anthony M Marino, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretaseCarl P Bergstrom, Charles P Sloan, Wai-Yu Lau, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 2, 2009
Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme inductionM Zheng, J Wang, J Lubinski, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Hydroxytriamides as potent gamma-secretase inhibitorsC V C Prasad, Owen B Wallace, Jeffrey W Noonan, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretaseCarl P Bergstrom, Charles P Sloan, Henry H Wang, et al.
BMC Microbiology|July 10, 2026
Plasmids of co-circulating Staphylococcus aureus serve as vehicles for antimicrobial resistance sharing across diseased host-species at short timescalesKathryn R Piper, Ana Beatriz Garcez Buiatte, Stephanie S R Souza, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2004
Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitorD M Barten, V L Guss, J A Corsa, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
Pageof 3